期刊文献+

三种喹诺酮类药三联方对幽门螺杆菌体内外抗菌效果对比研究 被引量:2

In Vivo and Vitro Antibiatic Offects of 3 Quinalones Triple Therapy Against Hp:Controlle Study
下载PDF
导出
摘要 目的:评价三种喹诺酮类药与阿莫西林对180株幽门螺杆菌(Hp)体外联合抗菌效应和临床根除率。方法:测定三种喹诺酮类药(环丙沙星、左氧氟沙星、莫西沙星)分别与阿莫西林单用及联用对180株Hp的最低抑菌浓度(MIC),计算其联合药敏指数(FIC值),并观察三种喹诺酮类药与奥美拉唑三联方根除Hp感染的疗效。结果:三种喹诺酮类药与阿莫西林联用对Hp致病菌的MIC值均显著降低。环丙沙星FIC值:0.75~1为相加作用;左氧氟沙星FIC值0.5~0.75为相加作用,莫西沙星FIC值;0.09375~0.1875为协同作用。三种喹诺酮类药与奥美拉唑的三联方对Hp临床根除率分别为93.33%、73.33%和61.67%,P<0.05。结论:三种喹诺酮类药与阿莫西林联用对180株Hp抗菌作用增强以协同作用和相加作用为主,无拮抗效应,其Hp根除率排序:莫西沙星>左氧氟沙星>环丙沙星。 Objective:To valuate the antibiotic effects in vitro of 3 quinolones combined with Amoxillin against 180 Helicobacter pylori(Hp) and Hp eradication rate in Our Hospital clinic.Methods:The MIC of ciprofloxacin and Amoxillin,Levofloxacin and Amorillin,Moxilloxacin and Amoxillin alone or in combination against 180 strains Hp were detected and FIC index was calculated according to MIC values.To obverse the curative effect of 3 quinolones and omeprazole tripl therapy on eradication of Hp infection.Results:The MIC of 3 quinolones combined with Amoxillin against Hp was reduced significantly.FIC index of ciprofloxacin 0.75--1.0 was additive action;FIC index of Levoftoxacin;0.5-0.75 was additive action.FIC index of Moxifloxacin:0.09375-0.1875 was synergism action,The Hp eradication rate in Our clinic of 3 quinalones and Omeprazole tripl therapy was 93.33%, 73.33% and 61.67%,respectively.P〈0.05.Conelusion:The antibiotic activity of 3 quinolones combined with Amoxillin against t 80 ttp strains was enhanced significantly.Their was characterized by synergism and additive action instead of antagonistic effect.The Hp eradication rate was Moxifloxacin〉lovefloxacin〉Ciprofloxacin.
出处 《中国医药导刊》 2010年第3期366-367,共2页 Chinese Journal of Medicinal Guide
关键词 喹诺酮类药 莫西沙星 阿莫西林 奥美拉唑 联合用药 三联方 幽门螺杆菌根除率 Quinolone Moxifloxacin Amoxillin Omeprazole Coadministration Triple therapy Eradication of Helicobacter pylori(Hp)
  • 相关文献

参考文献6

  • 1王改芹,谢佳平,金红.66例幽门螺杆菌感染者耐药性分析[J].临床内科杂志,2008,25(11):747-749. 被引量:12
  • 2Kanellakopoulou K,Sarafis P, Galani I,et al.In vitro synergism of beta- lactams with ciprofloxacin and moxifloxacin against genetically distinct multidrug-resistant isolates of psoudomonas aeruginosa[J].Int J Antimicrob Agents,2008;32(1):33-39.
  • 3胡伏莲,胡品津,刘文忠,王继德,吕农华,萧树东,张万岱,成虹,谢勇.第三次全国幽门螺杆菌感染若干问题共识报告[J].胃肠病学,2008,13(1):42-46. 被引量:388
  • 4荚恒敏,马筱玲,张义永.喹诺酮类药物耐药机制及临床用药方案[J].中国感染与化疗杂志,2009,9(2):154-157. 被引量:27
  • 5Cheon JM,Kin N,Lee DH,et al.Trial of moxifloxacin-containing triple therapy after initial and second-line treatment failtures for helicobacter pylori infection[J].Korean J Gastroenteral,2005;45:111- 117.
  • 6Bago P, Vcev A,Tomic M,et al.High eradication rate of H,pylori with moxifloxacin- base Ueatment:a randomiged controlled trial[J].Wien Klin woehenschr,2007;119(11 -12):372.

二级参考文献43

共引文献420

同被引文献21

  • 1王志坤,刘启泉,刘晓辉.五味消毒饮与黄芪建中汤配合西药治疗胃溃疡及幽门螺杆菌感染73例[J].陕西中医,2007,28(1):31-32. 被引量:11
  • 2王静,张淑文.中药逆转细菌耐药的研究进展[J].临床和实验医学杂志,2007,6(1):153-155. 被引量:58
  • 3Boyanova L, Gergova G, Nikolov R, et al. Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods[J]. Diagn Micro- biol Infect Dis,2008,60(4):409-415.
  • 4Shih YT, Wu DC, Liu CM, et al. San - Huang - Xie - Xin - Tang inhibits Helicobacter pylori- induced inflammation in human gastric epithelialAGS cells [J ]. J Ethnopharmacol, 2007,112 (3) : 537 - 544.
  • 5Lo YC, Lin YL, Yu KL, et al. San - Huang - Xie - Xin - Tang attenuates inflammatory responses in lipopolysaecharide-exposed rat lungs[J] .J Ethnopharmaeol,2005,101 ( 1 - 3 ): 68 - 74.
  • 6Bago P, Vcev A, Tomic M, et al. High eradication rate of H. pylori with moxifloxacin-based treatment: a randomized controlled trial[J].Wien Klin Wochenschr,2007,119(11 - 12): 372 -378.
  • 7Cheon JH, Kim N, Lee DH, et al. Trial of moxifloxacin-containing triple therapy after initial and second- line treatment failures for He- licobacter pylori infection[J ] . Korean J Gastroenterol, 2005, 45 (2): 111 -117.
  • 8Li J,Zhao J, Hamer - Maansson JE,et al. esomeprazole in adolescent patients aged toms of gastroesophageal reflux disease: Pharmacokinetic proper6es of 12 to 17 years with syrup- study[J]. Clin Ther,2006,28(3):419 -427.
  • 9胡伏莲,胡品津,刘文忠,王继德,吕农华,萧树东,张万岱,成虹,谢勇.第三次全国幽门螺杆菌感染若干问题共识报告[J].胃肠病学,2008,13(1):42-46. 被引量:388
  • 10杨立荣.左氧氟沙星治疗耐多药肺结核临床疗效分析[J].中国实用医药,2008,3(14):86-87. 被引量:10

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部